Boutique Corporation, RMUTL sign MOU to research and develop products for Thai traditional wellness based on hemp and cannabis

Food and Healthcare Press Releases Wednesday October 28, 2020 16:33
Bangkok--28 Oct--IR PLUS
Bespoke Life Science Limited, a company under Boutique Corporation PCL, and Rajamangala University of Technology Lanna has signed the Memorandum of Understanding (MOU).
The purpose of the MOU are to cooperate and to promote research and development, cultivation,processing and developing products for Thai traditional wellness based on hemp and cannabis.
The MOU lays a cornerstone for Boutique Corporation's diversification into wellness hospitality, complimenting Boutique Corporation's core business in the hospitality and real estate sector.

Dr.Suraphon Chaiwongsar, Vice President for Research and Academic Services Rajamangala University of Technology and Mr. Prabsharan Singh Trakral, President and Group CEO of Boutique Corporation PCL joining the signing ceremony on 27th October, 2020 at Novotel Chiangmai Nimman Journeyhub, Chiangmai.

Bespoke Life Science Limited will be structured similar to that of a private equity fund, in line with how Boutique Corporation PCL structures most of its hotel and real estate investments.

Latest Press Release

Ministry of Public Health and Department of Health Service Support leverage leading technologies to expand Alternative State Quarantine (ASQ)

Ministry of Public Health (MOPH) and Department of Health Service Support (HSS) today announced they will leverage Agoda's cutting edge digital technologies to further improve accessibility and efficiency for the booking processes of Alternative States...

European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC)...

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

MedAlliance has announced completion of patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR(TM) 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis....

INSIGHTEC Announces MR-guided Focused Ultrasound to Treat Essential Tremor Received Funding by National Health Service (NHS) England

INSIGHTEC(R), a global healthcare company focused on the therapeutic power of acoustic energy, today announced that the National Health Service (NHS) England has approved funding for MR-guided Focused Ultrasound for the treatment of medication-refractory...

NPL and Cambridge Quantum Computing (CQC) collaborate in quantum computing

- NPL supports Cambridge Quantum Computing to accelerate R&D through to commercialisation of their novel quantum photonic products - Incubation and collaboration with pioneering companies helps drive innovation within UK quantum sector Scientists...

Related Topics